Selected research
Market Analysis & Forecast
Global Obeticholic Acid Drug Market Analysis and Forecast 2026-2032
Market perspective
The global Obeticholic Acid Drug market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Obeticholic Acid Drug is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Europe market for Obeticholic Acid Drug is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Read the full market overview
Asia-Pacific market for Obeticholic Acid Drug is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The China market for Obeticholic Acid Drug is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The major global manufacturers of Obeticholic Acid Drug include Intercept Pharmaceuticals and Dainippon Sumitomo Pharma etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.
This report presents an overview of global market for Obeticholic Acid Drug, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.
This report researches the key producers of Obeticholic Acid Drug, also provides the sales of main regions and countries. Of the upcoming market potential for Obeticholic Acid Drug, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Obeticholic Acid Drug sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Obeticholic Acid Drug market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Obeticholic Acid Drug sales, projected growth trends, production technology, application and end-user industry.
Obeticholic Acid Drug Segment by Company
Intercept Pharmaceuticals
Dainippon Sumitomo Pharma
Obeticholic Acid Drug Segment by Type
5mg
10mg
Obeticholic Acid Drug Segment by Application
Primary Biliary Cirrhosis
Nonalcoholic Fatty Liver Disease
Other
Obeticholic Acid Drug Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Study Objectives
1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Obeticholic Acid Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Obeticholic Acid Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Obeticholic Acid Drug.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Sales (consumption), revenue of Obeticholic Acid Drug in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 4: Detailed analysis of Obeticholic Acid Drug manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Obeticholic Acid Drug sales, revenue, price, gross margin, and recent development, etc.
Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.
Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.
Chapter 10: China type, by application, sales, and revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.
Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.
Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 14: The main concluding insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- 5mg
- 10mg
Applications
- Primary Biliary Cirrhosis
- Nonalcoholic Fatty Liver Disease
- Other
Companies covered
- Intercept Pharmaceuticals
- Dainippon Sumitomo Pharma
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Obeticholic Acid Drug Market by Type
- 1.2.1 Global Obeticholic Acid Drug Market Size by Type, 2021 VS 2025 VS 2032
- 1.2.2 5mg
- 1.2.3 10mg
- 1.3 Obeticholic Acid Drug Market by Application
- 1.3.1 Global Obeticholic Acid Drug Market Size by Application, 2021 VS 2025 VS 2032
- 1.3.2 Primary Biliary Cirrhosis
- 1.3.3 Nonalcoholic Fatty Liver Disease
- 1.3.4 Other
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 Obeticholic Acid Drug Market Dynamics
- 2.1 Obeticholic Acid Drug Industry Trends
- 2.2 Obeticholic Acid Drug Industry Drivers
- 2.3 Obeticholic Acid Drug Industry Opportunities and Challenges
- 2.4 Obeticholic Acid Drug Industry Restraints
3 Global Market Growth Prospects
- 3.1 Global Obeticholic Acid Drug Revenue Estimates and Forecasts (2021-2032)
- 3.2 Global Obeticholic Acid Drug Revenue by Region
- 3.2.1 Global Obeticholic Acid Drug Revenue by Region: 2021 VS 2025 VS 2032
- 3.2.2 Global Obeticholic Acid Drug Revenue by Region (2021-2026)
- 3.2.3 Global Obeticholic Acid Drug Revenue by Region (2027-2032)
- 3.2.4 Global Obeticholic Acid Drug Revenue Market Share by Region (2021-2032)
- 3.3 Global Obeticholic Acid Drug Sales Estimates and Forecasts 2021-2032
- 3.4 Global Obeticholic Acid Drug Sales by Region
- 3.4.1 Global Obeticholic Acid Drug Sales by Region: 2021 VS 2025 VS 2032
- 3.4.2 Global Obeticholic Acid Drug Sales by Region (2021-2026)
- 3.4.3 Global Obeticholic Acid Drug Sales by Region (2027-2032)
- 3.4.4 Global Obeticholic Acid Drug Sales Market Share by Region (2021-2032)
- 3.5 US & Canada & Mexico
- 3.6 Europe
- 3.7 China
- 3.8 Asia (Excluding China)
- 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
- 4.1 Global Obeticholic Acid Drug Revenue by Manufacturers
- 4.1.1 Global Obeticholic Acid Drug Revenue by Manufacturers (2021-2026)
- 4.1.2 Global Obeticholic Acid Drug Revenue Market Share by Manufacturers (2021-2026)
- 4.1.3 Global Obeticholic Acid Drug Manufacturers Revenue Share Top 10 and Top 5 in 2025
- 4.2 Global Obeticholic Acid Drug Sales by Manufacturers
- 4.2.1 Global Obeticholic Acid Drug Sales by Manufacturers (2021-2026)
- 4.2.2 Global Obeticholic Acid Drug Sales Market Share by Manufacturers (2021-2026)
- 4.2.3 Global Obeticholic Acid Drug Manufacturers Sales Share Top 10 and Top 5 in 2025
- 4.3 Global Obeticholic Acid Drug Sales Price by Manufacturers (2021-2026)
- 4.4 Global Obeticholic Acid Drug Key Manufacturers Ranking, 2024 VS 2025 VS 2026
- 4.5 Global Obeticholic Acid Drug Key Manufacturers Manufacturing Sites & Headquarters
- 4.6 Global Obeticholic Acid Drug Manufacturers, Product Type & Application
- 4.7 Global Obeticholic Acid Drug Manufacturers' Establishment Date
- 4.8 Market Competitive Analysis
- 4.8.1 Global Obeticholic Acid Drug Market CR5 and HHI
- 4.8.2 2025 Obeticholic Acid Drug Tier 1, Tier 2, and Tier 3
5 Obeticholic Acid Drug Market by Type
- 5.1 Global Obeticholic Acid Drug Revenue by Type
- 5.1.1 Global Obeticholic Acid Drug Revenue by Type (2021 VS 2025 VS 2032)
- 5.1.2 Global Obeticholic Acid Drug Revenue by Type (2021-2032) & (US$ Million)
- 5.1.3 Global Obeticholic Acid Drug Revenue Market Share by Type (2021-2032)
- 5.2 Global Obeticholic Acid Drug Sales by Type
- 5.2.1 Global Obeticholic Acid Drug Sales by Type (2021 VS 2025 VS 2032)
- 5.2.2 Global Obeticholic Acid Drug Sales by Type (2021-2032) & (K Units)
- 5.2.3 Global Obeticholic Acid Drug Sales Market Share by Type (2021-2032)
- 5.3 Global Obeticholic Acid Drug Price by Type
6 Obeticholic Acid Drug Market by Application
- 6.1 Global Obeticholic Acid Drug Revenue by Application
- 6.1.1 Global Obeticholic Acid Drug Revenue by Application (2021 VS 2025 VS 2032)
- 6.1.2 Global Obeticholic Acid Drug Revenue by Application (2021-2032) & (US$ Million)
- 6.1.3 Global Obeticholic Acid Drug Revenue Market Share by Application (2021-2032)
- 6.2 Global Obeticholic Acid Drug Sales by Application
- 6.2.1 Global Obeticholic Acid Drug Sales by Application (2021 VS 2025 VS 2032)
- 6.2.2 Global Obeticholic Acid Drug Sales by Application (2021-2032) & (K Units)
- 6.2.3 Global Obeticholic Acid Drug Sales Market Share by Application (2021-2032)
- 6.3 Global Obeticholic Acid Drug Price by Application
7 Company Profiles
- 7.1 Intercept Pharmaceuticals
- 7.1.1 Intercept Pharmaceuticals Company Information
- 7.1.2 Intercept Pharmaceuticals Business Overview
- 7.1.3 Intercept Pharmaceuticals Obeticholic Acid Drug Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.1.4 Intercept Pharmaceuticals Obeticholic Acid Drug Product Portfolio
- 7.1.5 Intercept Pharmaceuticals Recent Developments
- 7.2 Dainippon Sumitomo Pharma
- 7.2.1 Dainippon Sumitomo Pharma Company Information
- 7.2.2 Dainippon Sumitomo Pharma Business Overview
- 7.2.3 Dainippon Sumitomo Pharma Obeticholic Acid Drug Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.2.4 Dainippon Sumitomo Pharma Obeticholic Acid Drug Product Portfolio
- 7.2.5 Dainippon Sumitomo Pharma Recent Developments
8 North America
- 8.1 North America Obeticholic Acid Drug Market Size by Type
- 8.1.1 North America Obeticholic Acid Drug Revenue by Type (2021-2032)
- 8.1.2 North America Obeticholic Acid Drug Sales by Type (2021-2032)
- 8.1.3 North America Obeticholic Acid Drug Price by Type (2021-2032)
- 8.2 North America Obeticholic Acid Drug Market Size by Application
- 8.2.1 North America Obeticholic Acid Drug Revenue by Application (2021-2032)
- 8.2.2 North America Obeticholic Acid Drug Sales by Application (2021-2032)
- 8.2.3 North America Obeticholic Acid Drug Price by Application (2021-2032)
- 8.3 North America Obeticholic Acid Drug Market Size by Country
- 8.3.1 North America Obeticholic Acid Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 8.3.2 North America Obeticholic Acid Drug Sales by Country (2021 VS 2025 VS 2032)
- 8.3.3 North America Obeticholic Acid Drug Price by Country (2021-2032)
- 8.3.4 United States
- 8.3.5 Canada
9 Europe
- 9.1 Europe Obeticholic Acid Drug Market Size by Type
- 9.1.1 Europe Obeticholic Acid Drug Revenue by Type (2021-2032)
- 9.1.2 Europe Obeticholic Acid Drug Sales by Type (2021-2032)
- 9.1.3 Europe Obeticholic Acid Drug Price by Type (2021-2032)
- 9.2 Europe Obeticholic Acid Drug Market Size by Application
- 9.2.1 Europe Obeticholic Acid Drug Revenue by Application (2021-2032)
- 9.2.2 Europe Obeticholic Acid Drug Sales by Application (2021-2032)
- 9.2.3 Europe Obeticholic Acid Drug Price by Application (2021-2032)
- 9.3 Europe Obeticholic Acid Drug Market Size by Country
- 9.3.1 Europe Obeticholic Acid Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 9.3.2 Europe Obeticholic Acid Drug Sales by Country (2021 VS 2025 VS 2032)
- 9.3.3 Europe Obeticholic Acid Drug Price by Country (2021-2032)
- 9.3.4 Germany
- 9.3.5 France
- 9.3.6 U.K.
- 9.3.7 Italy
- 9.3.8 Netherlands
10 China
- 10.1 China Obeticholic Acid Drug Market Size by Type
- 10.1.1 China Obeticholic Acid Drug Revenue by Type (2021-2032)
- 10.1.2 China Obeticholic Acid Drug Sales by Type (2021-2032)
- 10.1.3 China Obeticholic Acid Drug Price by Type (2021-2032)
- 10.2 China Obeticholic Acid Drug Market Size by Application
- 10.2.1 China Obeticholic Acid Drug Revenue by Application (2021-2032)
- 10.2.2 China Obeticholic Acid Drug Sales by Application (2021-2032)
- 10.2.3 China Obeticholic Acid Drug Price by Application (2021-2032)
11 Asia (Excluding China)
- 11.1 Asia Obeticholic Acid Drug Market Size by Type
- 11.1.1 Asia Obeticholic Acid Drug Revenue by Type (2021-2032)
- 11.1.2 Asia Obeticholic Acid Drug Sales by Type (2021-2032)
- 11.1.3 Asia Obeticholic Acid Drug Price by Type (2021-2032)
- 11.2 Asia Obeticholic Acid Drug Market Size by Application
- 11.2.1 Asia Obeticholic Acid Drug Revenue by Application (2021-2032)
- 11.2.2 Asia Obeticholic Acid Drug Sales by Application (2021-2032)
- 11.2.3 Asia Obeticholic Acid Drug Price by Application (2021-2032)
- 11.3 Asia Obeticholic Acid Drug Market Size by Country
- 11.3.1 Asia Obeticholic Acid Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 11.3.2 Asia Obeticholic Acid Drug Sales by Country (2021 VS 2025 VS 2032)
- 11.3.3 Asia Obeticholic Acid Drug Price by Country (2021-2032)
- 11.3.4 Japan
- 11.3.5 South Korea
- 11.3.6 India
- 11.3.7 Australia
- 11.3.8 Taiwan
- 11.3.9 Southeast Asia
12 South America, Middle East and Africa
- 12.1 SAMEA Obeticholic Acid Drug Market Size by Type
- 12.1.1 SAMEA Obeticholic Acid Drug Revenue by Type (2021-2032)
- 12.1.2 SAMEA Obeticholic Acid Drug Sales by Type (2021-2032)
- 12.1.3 SAMEA Obeticholic Acid Drug Price by Type (2021-2032)
- 12.2 SAMEA Obeticholic Acid Drug Market Size by Application
- 12.2.1 SAMEA Obeticholic Acid Drug Revenue by Application (2021-2032)
- 12.2.2 SAMEA Obeticholic Acid Drug Sales by Application (2021-2032)
- 12.2.3 SAMEA Obeticholic Acid Drug Price by Application (2021-2032)
- 12.3 SAMEA Obeticholic Acid Drug Market Size by Country
- 12.3.1 SAMEA Obeticholic Acid Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 12.3.2 SAMEA Obeticholic Acid Drug Sales by Country (2021 VS 2025 VS 2032)
- 12.3.3 SAMEA Obeticholic Acid Drug Price by Country (2021-2032)
- 12.3.4 Brazil
- 12.3.5 Argentina
- 12.3.6 Chile
- 12.3.7 Colombia
- 12.3.8 Peru
- 12.3.9 Saudi Arabia
- 12.3.10 Israel
- 12.3.11 UAE
- 12.3.12 Turkey
- 12.3.13 Iran
- 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
- 13.1 Obeticholic Acid Drug Value Chain Analysis
- 13.1.1 Obeticholic Acid Drug Key Raw Materials
- 13.1.2 Raw Materials Key Suppliers
- 13.1.3 Manufacturing Cost Structure
- 13.1.4 Obeticholic Acid Drug Production Mode & Process
- 13.2 Obeticholic Acid Drug Sales Channels Analysis
- 13.2.1 Direct Comparison with Distribution Share
- 13.2.2 Obeticholic Acid Drug Distributors
- 13.2.3 Obeticholic Acid Drug Customers
14 Concluding Insights
15 Appendix
- 15.1 Reasons for Doing This Study
- 15.2 Research Methodology
- 15.3 Research Process
- 15.4 Authors List of This Report
- 15.5 Data Source
- 15.5.1 Secondary Sources
- 15.5.2 Primary Sources
- 15.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst